New Zealand's cervical screening programme, a vital tool in the fight against cancer, has been quietly failing thousands of people. A damning review released on Monday reveals that nearly a million notifications for screening were either not triggered or not sent, raising serious questions about equity and access in our healthcare system.
The review, conducted by a Health New Zealand expert panel, found that while the national register is working in many ways, its clinical safety cannot be guaranteed. The system, designed to catch cervical cancer early, has been leaving people in the dark.
What Went Wrong with the Screening Register?
The core issue lies in the register's design and construction. As of June 2025, over 800,000 notifications were never triggered, and another 160,000 were triggered but never sent. The biggest culprit is the so-called 'NHI active rule', which automatically marks anyone who hasn't accessed health services for three years as 'inactive'. This rule alone prevented more than 600,000 notifications from being sent.
Other factors include incorrect or missing postal addresses. A process called 'cohorting', meant to prioritise the most vulnerable, also backfired. It only sent notifications to the highest priority group: people ageing into the scheme, and unscreened or under-screened Māori and Pasifika people not enrolled in primary care. While this sounds targeted, it meant many others were simply ignored.
Who Was Left Out?
The review highlights a stark inequality. The system's flaws disproportionately affect those who are already marginalised. People who are inactive in the health system, often due to poverty, mobility issues, or distrust, are the ones most likely to miss out. The register also lacks complete screening histories, meaning it cannot properly assess risk for people with complex histories, like those with previous high-grade results or persistent HPV infections.
The panel was blunt: 'Failure to do so poses a significant risk to affected individuals, potentially leading to delayed diagnosis or treatment.' This is not just a technical glitch. It is a systemic failure that could have deadly consequences.
What Are the Recommendations?
The review makes 48 recommendations. The most urgent is to identify and contact all unscreened and under-screened people as a priority. The system must also ensure proper follow-up when abnormalities are detected. Health NZ's Digital Services and the National Cervical Screening Programme are now tasked with developing an action plan.
Alana Ewe-Snow, director of prevention screening at the National Public Health Service, acknowledged the problem. 'We acknowledge there is further work to do to improve the register,' she said. 'We are working hard to address the panel's recommendations. The main recommendations centred around improving clinical case review, data quality and notifications to women.'
Is There Any Good News?
Despite the failures, screening rates are actually higher than ever, thanks to the introduction of HPV primary screening in September 2023. More than a million people have been screened since the register was introduced. 'This progress is heartening but there is much more work to do,' Ewe-Snow said. 'Improvements to the register will mean we can reach even more women for screening.'
So far, 13,000 case reviews have been conducted, and there is no evidence that anyone has been harmed. But the margin for error is slim. 'We are well on the way towards enacting the panel's recommendations,' Ewe-Snow added. 'We've completed six already with a further 11 in progress.'
What Does This Mean for New Zealanders?
For a country that prides itself on fairness and innovation, this is a sobering wake-up call. Our healthcare system is only as strong as its most vulnerable users. If a million people are being missed, the system is not just flawed. It is failing. The challenge now is to turn these recommendations into real, equitable change. Because when it comes to cancer, every missed notification is a potential life lost.